Johnson & Johnson Secures FDA Approval for ICOTYDE™ – A Breakthrough Oral Therapy for Plaque Psoriasis
Johnson & Johnson has secured approval from the U.S. Food and Drug Administration for ICOTYDE™, a once-daily oral therapy designed […]
oral peptide psoriasis drug